 |
PDBsum entry 2ctn
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Calcium-binding protein
|
PDB id
|
|
|
|
2ctn
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Calcium-binding protein
|
 |
|
Title:
|
 |
Structure of calcium-saturated cardiac troponin c, nmr, 30 structures
|
|
Structure:
|
 |
Troponin c. Chain: a. Fragment: regulatory n-domain residues 2 - 89. Synonym: ctnc. Engineered: yes. Mutation: yes. Other_details: cardiac troponin c with calcium ion bound at site ii
|
|
Source:
|
 |
Gallus gallus. Chicken. Organism_taxid: 9031. Cell_line: bl21. Organ: heart. Tissue: muscle. Cellular_location: thin filament. Gene: ctnc(a-cys). Expressed in: escherichia coli.
|
|
NMR struc:
|
 |
30 models
|
 |
|
Authors:
|
 |
S.K.Sia,M.X.Li,L.Spyracopoulos,S.M.Gagne,W.Liu,J.A.Putkey,B.D.Sykes
|
Key ref:
|
 |
S.K.Sia
et al.
(1997).
Structure of cardiac muscle troponin C unexpectedly reveals a closed regulatory domain.
J Biol Chem,
272,
18216-18221.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
06-May-97
|
Release date:
|
06-May-98
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P09860
(TNNC1_CHICK) -
Troponin C, slow skeletal and cardiac muscles from Gallus gallus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
161 a.a.
88 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 3 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
272:18216-18221
(1997)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of cardiac muscle troponin C unexpectedly reveals a closed regulatory domain.
|
|
S.K.Sia,
M.X.Li,
L.Spyracopoulos,
S.M.Gagné,
W.Liu,
J.A.Putkey,
B.D.Sykes.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The regulation of cardiac muscle contraction must differ from that of skeletal
muscles to effect different physiological and contractile properties. Cardiac
troponin C (TnC), the key regulator of cardiac muscle contraction, possesses
different functional and Ca2+-binding properties compared with skeletal TnC and
features a Ca2+-binding site I, which is naturally inactive. The structure of
cardiac TnC in the Ca2+-saturated state has been determined by nuclear magnetic
resonance spectroscopy. The regulatory domain exists in a "closed"
conformation even in the Ca2+-bound (the "on") state, in contrast to
all predicted models and differing significantly from the calcium-induced
structure observed in skeletal TnC. This structure in the Ca2+-bound state, and
its subsequent interaction with troponin I (TnI), are crucial in determining the
specific regulatory mechanism for cardiac muscle contraction. Further, it will
allow for an understanding of the action of calcium-sensitizing drugs, which
bind to cardiac TnC and are known to enhance the ability of cardiac TnC to
activate cardiac muscle contraction.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Structure of Ca^2+-saturated cardiac TnC as
determined in this study (sequence starts at Ala^2 and ends at
Val161). The -helices
are approximately as follows: N-helix (residues 6-10), A-helix
(14-28), B-helix (38-48), C-helix (54-64), D-helix (74-83),
E-helix (95-103), F-helix (114-123), G-helix (130-140), H-helix
(150-158). The antiparallel -sheets
connect residues 35-37 and 71-73 in the N-domain, and residues
111-113 and 147-149^ in the C-domain. All regions of the
molecule are well defined, with the exceptions of the following
regions: the N- and C-terminal residues (2-4 and 159-161),
residues 30-33 of defunct site I, residues 49-55 of the B-C
linker, residues 66-68 of site II, the^ central linker (86-94),
and residues 125-129 of the F-G linker. Stereo views of the
superposition of 30 structures for the regulatory N-domain
(residues 5-84, A) and the structural C-domain (95-158, B) are
shown. Positions of the Ca^2+ ions are indicated by gray
spheres. This figure was prepared^ with the program RASTER3D
(37).
|
 |
Figure 4.
Fig. 4. Comparison of the surface structures of the
regulatory N-domains of 4Ca·skeletal TnC (NMR) (A),
3Ca·cardiac TnC (NMR) (B), and 3Ca·cardiac TnC
(model, Ref. 9) (C), displayed in the same^ orientation as Fig.
1A. Side chains of hydrophobic residues (Ala, Ile, Leu, Met,
Pro, Phe, Tyr, and Val) are shown in yellow, negatively charged
residues (Asp and Glu) in red, positively charged^ residues (Arg
and Lys) in blue, and all other residues in gray. The major
hydrophobic pocket of 3Ca·cardiac TnC involves residues
Phe^20, Phe^24, Leu48, Phe^74, Phe^77, Leu78, Met81, and Met85,
and residues Ile^36, Leu41, Met45, Leu57, Met60, Ile^61, Val64,
Val72, and Met80. Other hydrophobic contacts are also observed
from Phe^20, Ala^23, and Phe^27 of the A-helix to Val44, Met47,
and Leu48 of the B-helix, and from Ala^8, Val9, and Leu12 of the
N-helix to Leu78, Val79, and Val82 of the D-helix. This figure
was generated using the program GRASP (38).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(1997,
272,
18216-18221)
copyright 1997.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
Y.B.Sun,
and
M.Irving
(2010).
The molecular basis of the steep force-calcium relation in heart muscle.
|
| |
J Mol Cell Cardiol,
48,
859-865.
|
 |
|
|
|
|
 |
I.M.Robertson,
M.X.Li,
and
B.D.Sykes
(2009).
Solution structure of human cardiac troponin C in complex with the green tea polyphenol, (-)-epigallocatechin 3-gallate.
|
| |
J Biol Chem,
284,
23012-23023.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Johnson,
L.Bruschweiler-Li,
S.A.Showalter,
G.W.Vuister,
F.Zhang,
and
R.Brüschweiler
(2008).
Structure and dynamics of Ca2+-binding domain 1 of the Na+/Ca2+ exchanger in the presence and in the absence of Ca2+.
|
| |
J Mol Biol,
377,
945-955.
|
 |
|
|
|
|
 |
I.M.Robertson,
O.K.Baryshnikova,
M.X.Li,
and
B.D.Sykes
(2008).
Defining the binding site of levosimendan and its analogues in a regulatory cardiac troponin C-troponin I complex.
|
| |
Biochemistry,
47,
7485-7495.
|
 |
|
|
|
|
 |
M.X.Li,
I.M.Robertson,
and
B.D.Sykes
(2008).
Interaction of cardiac troponin with cardiotonic drugs: a structural perspective.
|
| |
Biochem Biophys Res Commun,
369,
88-99.
|
 |
|
|
|
|
 |
O.K.Baryshnikova,
T.C.Williams,
and
B.D.Sykes
(2008).
Internal pH indicators for biomolecular NMR.
|
| |
J Biomol NMR,
41,
5-7.
|
 |
|
|
|
|
 |
A.Schmidtmann,
C.Lindow,
S.Villard,
A.Heuser,
A.Mügge,
R.Gessner,
C.Granier,
and
K.Jaquet
(2005).
Cardiac troponin C-L29Q, related to hypertrophic cardiomyopathy, hinders the transduction of the protein kinase A dependent phosphorylation signal from cardiac troponin I to C.
|
| |
FEBS J,
272,
6087-6097.
|
 |
|
|
|
|
 |
M.V.Vinogradova,
D.B.Stone,
G.G.Malanina,
C.Karatzaferi,
R.Cooke,
R.A.Mendelson,
and
R.J.Fletterick
(2005).
Ca(2+)-regulated structural changes in troponin.
|
| |
Proc Natl Acad Sci U S A,
102,
5038-5043.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Kobayashi,
and
R.J.Solaro
(2005).
Calcium, thin filaments, and the integrative biology of cardiac contractility.
|
| |
Annu Rev Physiol,
67,
39-67.
|
 |
|
|
|
|
 |
X.Wang,
P.Mercier,
P.J.Letourneau,
and
B.D.Sykes
(2005).
Effects of Phe-to-Trp mutation and fluorotryptophan incorporation on the solution structure of cardiac troponin C, and analysis of its suitability as a potential probe for in situ NMR studies.
|
| |
Protein Sci,
14,
2447-2460.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.Agianian,
U.Krzic,
F.Qiu,
W.A.Linke,
K.Leonard,
and
B.Bullard
(2004).
A troponin switch that regulates muscle contraction by stretch instead of calcium.
|
| |
EMBO J,
23,
772-779.
|
 |
|
|
|
|
 |
G.L.Gay,
D.A.Lindhout,
and
B.D.Sykes
(2004).
Using lanthanide ions to align troponin complexes in solution: order of lanthanide occupancy in cardiac troponin C.
|
| |
Protein Sci,
13,
640-651.
|
 |
|
|
|
|
 |
M.Regnier,
H.Martin,
R.J.Barsotti,
A.J.Rivera,
D.A.Martyn,
and
E.Clemmens
(2004).
Cross-bridge versus thin filament contributions to the level and rate of force development in cardiac muscle.
|
| |
Biophys J,
87,
1815-1824.
|
 |
|
|
|
|
 |
M.X.Li,
X.Wang,
and
B.D.Sykes
(2004).
Structural based insights into the role of troponin in cardiac muscle pathophysiology.
|
| |
J Muscle Res Cell Motil,
25,
559-579.
|
 |
|
|
|
|
 |
B.D.Sykes
(2003).
Pulling the calcium trigger.
|
| |
Nat Struct Biol,
10,
588-589.
|
 |
|
|
|
|
 |
C.Sheldahl,
J.Xing,
W.J.Dong,
S.C.Harvey,
and
H.C.Cheung
(2003).
The calcium-saturated cTnI/cTnC complex: structure of the inhibitory region of cTnI.
|
| |
Biophys J,
84,
1057-1064.
|
 |
|
|
|
|
 |
M.X.Li,
X.Wang,
D.A.Lindhout,
N.Buscemi,
J.E.Van Eyk,
and
B.D.Sykes
(2003).
Phosphorylation and mutation of human cardiac troponin I deferentially destabilize the interaction of the functional regions of troponin I with troponin C.
|
| |
Biochemistry,
42,
14460-14468.
|
 |
|
|
|
|
 |
D.A.Lindhout,
M.X.Li,
D.Schieve,
and
B.D.Sykes
(2002).
Effects of T142 phosphorylation and mutation R145G on the interaction of the inhibitory region of human cardiac troponin I with the C-domain of human cardiac troponin C.
|
| |
Biochemistry,
41,
7267-7274.
|
 |
|
|
|
|
 |
L.J.Brown,
K.L.Sale,
R.Hills,
C.Rouviere,
L.Song,
X.Zhang,
and
P.G.Fajer
(2002).
Structure of the inhibitory region of troponin by site directed spin labeling electron paramagnetic resonance.
|
| |
Proc Natl Acad Sci U S A,
99,
12765-12770.
|
 |
|
|
|
|
 |
D.A.Martyn,
and
A.M.Gordon
(2001).
Influence of length on force and activation-dependent changes in troponin c structure in skinned cardiac and fast skeletal muscle.
|
| |
Biophys J,
80,
2798-2808.
|
 |
|
|
|
|
 |
D.A.Martyn,
M.Regnier,
D.Xu,
and
A.M.Gordon
(2001).
Ca2+ - and cross-bridge-dependent changes in N- and C-terminal structure of troponin C in rat cardiac muscle.
|
| |
Biophys J,
80,
360-370.
|
 |
|
|
|
|
 |
K.Pääkkönen,
T.Sorsa,
T.Drakenberg,
P.Pollesello,
C.Tilgmann,
P.Permi,
S.Heikkinen,
I.Kilpeläinen,
and
A.Annila
(2000).
Conformations of the regulatory domain of cardiac troponin C examined by residual dipolar couplings.
|
| |
Eur J Biochem,
267,
6665-6672.
|
 |
|
|
|
|
 |
M.X.Li,
L.Spyracopoulos,
N.Beier,
J.A.Putkey,
and
B.D.Sykes
(2000).
Interaction of cardiac troponin C with Ca(2+) sensitizer EMD 57033 and cardiac troponin I inhibitory peptide.
|
| |
Biochemistry,
39,
8782-8790.
|
 |
|
|
|
|
 |
P.Kischel,
B.Bastide,
J.D.Potter,
and
Y.Mounier
(2000).
The role of the Ca(2+) regulatory sites of skeletal troponin C in modulating muscle fibre reactivity to the Ca(2+) sensitizer bepridil.
|
| |
Br J Pharmacol,
131,
1496-1502.
|
 |
|
|
|
|
 |
P.Mercier,
M.X.Li,
and
B.D.Sykes
(2000).
Role of the structural domain of troponin C in muscle regulation: NMR studies of Ca2+ binding and subsequent interactions with regions 1-40 and 96-115 of troponin I.
|
| |
Biochemistry,
39,
2902-2911.
|
 |
|
|
|
|
 |
R.T.McKay,
L.F.Saltibus,
M.X.Li,
and
B.D.Sykes
(2000).
Energetics of the induced structural change in a Ca2+ regulatory protein: Ca2+ and troponin I peptide binding to the E41A mutant of the N-domain of skeletal troponin C.
|
| |
Biochemistry,
39,
12731-12738.
|
 |
|
|
|
|
 |
W.J.Dong,
J.M.Robinson,
J.Xing,
P.K.Umeda,
and
H.C.Cheung
(2000).
An interdomain distance in cardiac troponin C determined by fluorescence spectroscopy.
|
| |
Protein Sci,
9,
280-289.
|
 |
|
|
|
|
 |
W.J.Dong,
J.Xing,
M.Chandra,
J.Solaro,
and
H.C.Cheung
(2000).
Structural mapping of single cysteine mutants of cardiac troponin I.
|
| |
Proteins,
41,
438-447.
|
 |
|
|
|
|
 |
Y.Li,
M.L.Love,
J.A.Putkey,
and
C.Cohen
(2000).
Bepridil opens the regulatory N-terminal lobe of cardiac troponin C.
|
| |
Proc Natl Acad Sci U S A,
97,
5140-5145.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.Wang,
W.Li,
M.R.Emmett,
A.G.Marshall,
D.Corson,
and
B.D.Sykes
(1999).
Fourier transform ion cyclotron resonance mass spectrometric detection of small Ca(2+)-induced conformational changes in the regulatory domain of human cardiac troponin C.
|
| |
J Am Soc Mass Spectrom,
10,
703-710.
|
 |
|
|
|
|
 |
G.M.Gasmi-Seabrook,
J.W.Howarth,
N.Finley,
E.Abusamhadneh,
V.Gaponenko,
R.M.Brito,
R.J.Solaro,
and
P.R.Rosevear
(1999).
Solution structures of the C-terminal domain of cardiac troponin C free and bound to the N-terminal domain of cardiac troponin I.
|
| |
Biochemistry,
38,
8313-8322.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Smith,
N.J.Greenfield,
and
S.E.Hitchcock-DeGregori
(1999).
Mutations in the N- and D-helices of the N-domain of troponin C affect the C-domain and regulatory function.
|
| |
Biophys J,
76,
400-408.
|
 |
|
|
|
|
 |
M.X.Li,
L.Spyracopoulos,
and
B.D.Sykes
(1999).
Binding of cardiac troponin-I147-163 induces a structural opening in human cardiac troponin-C.
|
| |
Biochemistry,
38,
8289-8298.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Kischel,
L.Stevens,
and
Y.Mounier
(1999).
Differential effects of bepridil on functional properties of troponin C in slow and fast skeletal muscles.
|
| |
Br J Pharmacol,
128,
767-773.
|
 |
|
|
|
|
 |
R.T.McKay,
B.P.Tripet,
J.R.Pearlstone,
L.B.Smillie,
and
B.D.Sykes
(1999).
Defining the region of troponin-I that binds to troponin-C.
|
| |
Biochemistry,
38,
5478-5489.
|
 |
|
|
|
|
 |
L.Spyracopoulos,
S.M.Gagné,
M.X.Li,
and
B.D.Sykes
(1998).
Dynamics and thermodynamics of the regulatory domain of human cardiac troponin C in the apo- and calcium-saturated states.
|
| |
Biochemistry,
37,
18032-18044.
|
 |
|
|
|
|
 |
R.T.McKay,
J.R.Pearlstone,
D.C.Corson,
S.M.Gagné,
L.B.Smillie,
and
B.D.Sykes
(1998).
Structure and interaction site of the regulatory domain of troponin-C when complexed with the 96-148 region of troponin-I.
|
| |
Biochemistry,
37,
12419-12430.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Spyracopoulos,
M.X.Li,
S.K.Sia,
S.M.Gagné,
M.Chandra,
R.J.Solaro,
and
B.D.Sykes
(1997).
Calcium-induced structural transition in the regulatory domain of human cardiac troponin C.
|
| |
Biochemistry,
36,
12138-12146.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |